G. Merola

TLR9 agonist acts by different mechanisms synergizing with bevacizumab in sensitive and cetuximab-resistant colon cancer xenografts

Vincenzo Damiano, Rosa Caputo, Sonia Garofalo et al. · Proceedings of the National Academy of Sciences · 2007 · 71 citations · Full text

Life Sciences, Oncology, Pharmacology +15

Preliminary results of phase II study of capecitabine and gemcitabine (CAP-GEM) in patients with metastatic pretreated thymic epithelial tumors (TETs)

Giovannella Palmieri, G. Merola, Piera Federico et al. · Annals of Oncology · 2009 · 55 citations

Medicine, Oncology, Chemotherapy +15

Imatinib mesylate in thymic epithelial malignancies

Giovannella Palmieri, Mirella Marino, Carlo Buonerba et al. · Cancer Chemotherapy and Pharmacology · 2011 · 48 citations

Medicine, Immunology, Oncology +7

A Novel Toll-Like Receptor 9 Agonist Cooperates with Trastuzumab in Trastuzumab-Resistant Breast Tumors through Multiple Mechanisms of Action

Vincenzo Damiano, Sonia Garofalo, Roberta Rosa et al. · Clinical Cancer Research · 2009 · 34 citations

Medicine, Oncology, Pharmacology +17